Arranta bio announced that it has received $82 million in funding from thermo fisher scientific inc., ampersand capital partners, and other investors

Arranta bio announced that it has received $82,000,000 in a round of funding on october 30, 2019. the transaction included participation from ampersand capital partners, new investor thermo fisher scientific inc. (nyse:tmo), and company founders and colleagues.

TMO Ratings Summary

TMO Quant Ranking